# | Title | Journal | Year | Citations |
---|
1 | Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 996 |
2 | Regulation of the Inflammatory Response in Cardiac Repair | Circulation Research | 2012 | 940 |
3 | TGF-β signaling in fibrosis | Growth Factors | 2011 | 908 |
4 | Transforming growth factor (TGF)-β signaling in cardiac remodeling | Journal of Molecular and Cellular Cardiology | 2011 | 828 |
5 | Pathophysiology of Myocardial Infarction | | 2015 | 437 |
6 | Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence | Journal of Clinical Medicine | 2020 | 411 |
7 | Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated Signaling | Diabetes | 2008 | 373 |
8 | Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure | Circulation Research | 2009 | 357 |
9 | Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure | Journal of the American College of Cardiology | 1999 | 317 |
10 | Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 306 |
11 | A new gaseous signaling molecule emerges: Cardioprotective role of hydrogen sulfide | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 304 |
12 | Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque | Circulation | 2020 | 282 |
13 | Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling | American Journal of Physiology - Heart and Circulatory Physiology | 2008 | 272 |
14 | Diabetic cardiomyopathy | Progress in Cardiovascular Diseases | 1985 | 261 |
15 | Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference | Kidney International | 2019 | 232 |
16 | Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug | Blood | 2010 | 224 |
17 | Prevalence and Characterization of Asymptomatic Pacemaker and ICD Lead Perforation on CT | PACE - Pacing and Clinical Electrophysiology | 2007 | 207 |
18 | Aging and Cardiac Fibrosis | | 2011 | 201 |
19 | Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities | Translational Research | 2014 | 200 |
20 | Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart Failure | Circulation | 2000 | 199 |
21 | IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium | Journal of Immunology | 2013 | 194 |
22 | Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure | American Journal of Cardiology | 1983 | 168 |
23 | Accuracy of Transcranial Doppler for the Diagnosis of Intracardiac Right-to-Left Shunt | JACC: Cardiovascular Imaging | 2014 | 153 |
24 | Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure | Journal of the American College of Cardiology | 1986 | 149 |
25 | Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs | Nanomedicine | 2015 | 148 |
26 | The Immune System and the Remodeling Infarcted Heart | Journal of Cardiovascular Pharmacology | 2014 | 137 |
27 | Demonstration of Left Ventricular Outflow Tract Eccentricity by Real Time 3D Echocardiography: Implications for the Determination of Aortic Valve Area | Echocardiography | 2007 | 133 |
28 | Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes | Journal of the American College of Cardiology | 2001 | 132 |
29 | The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry | Journal of the American College of Cardiology | 2000 | 129 |
30 | Experimental Diabetes Is Associated With Functional Activation of Protein Kinase Cε and Phosphorylation of Troponin I in the Heart, Which Are Prevented by Angiotensin II Receptor Blockade | Circulation Research | 1997 | 125 |
31 | Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management | American Heart Journal | 1979 | 124 |
32 | Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CT | International Journal of Cardiovascular Imaging | 2009 | 121 |
33 | Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure | American Journal of Cardiology | 1981 | 119 |
34 | Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism | Hypertension | 2011 | 119 |
35 | Cardiac malformations in the velocardiofacial syndrome | American Journal of Cardiology | 1980 | 113 |
36 | Myostatin activation in patients with advanced heart failure and after mechanical unloading | European Journal of Heart Failure | 2010 | 113 |
37 | Endothelial Cell Activation in Patients With Decompensated Heart Failure | Circulation | 2005 | 112 |
38 | Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation | Journal of the American College of Cardiology | 2011 | 111 |
39 | Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects | American Heart Journal | 1979 | 108 |
40 | Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock | American Heart Journal | 2008 | 108 |
41 | Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias | Progress in Cardiovascular Diseases | 1981 | 107 |
42 | Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure | American Journal of Cardiology | 1980 | 106 |
43 | Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement | JACC: Cardiovascular Interventions | 2017 | 106 |
44 | The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size | American Heart Journal | 1993 | 103 |
45 | Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blocker | American Heart Journal | 1979 | 99 |
46 | Systematic Characterization of Myocardial Inflammation, Repair, and Remodeling in a Mouse Model of Reperfused Myocardial Infarction | Journal of Histochemistry and Cytochemistry | 2013 | 99 |
47 | Derived Indexes of Ventricular and Myocardial Function | New England Journal of Medicine | 1977 | 97 |
48 | Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications | American Heart Journal | 1979 | 97 |
49 | Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis | Journal of the American College of Cardiology | 2021 | 97 |
50 | Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program | Circulation Research | 2019 | 96 |